Document is current
Any future updates will be listed below
-
Authors
Bertrand, Nicolas
Grenier, Philippe
Mahmoudi, Morteza https://orcid.org/0000-0002-2575-9684
Lima, Eliana M. https://orcid.org/0000-0003-1231-5803
Appel, Eric A. https://orcid.org/0000-0002-2301-7126
Dormont, Flavio
Lim, Jong-Min
Karnik, Rohit https://orcid.org/0000-0003-0588-9286
Langer, Robert
Farokhzad, Omid C.
- License Information
-
More Information
Article History
Received: 7 March 2017
Accepted: 11 July 2017
First Online: 3 October 2017
Competing interests
: O.C.F. and R.L. have financial interests in Tarveda Therapeutics, Selecta Biosciences and Placon Therapeutics. R.L. declares financial interests in Moderna. These biotechnology companies are developing nanoparticle technologies for medical applications. The remaining authors declare no competing financial interests.
